We found that the concentrations of five synaptic proteins (VGF, cadherin-2 (CDH2), NPTX2, BDNF and FXYD6) were reduced in preclinical AD relative to controls in EMIF-AD MBD. This evidence concerns the gene FXYD6 and Alzheimer disease.